Remove Business Development Remove Clinical Supply Chain Remove Development Remove Medicine
article thumbnail

Why demand is rising for secure and climate-controlled gene therapy services

Pharmaceutical Technology

Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide. Cell and gene therapies are not your typical clinical supply chain.

article thumbnail

Africa: Unleashing the potential of the new superpower in clinical trials

Pharmaceutical Technology

Africa has considerable advantages and opportunities for trialling investigational medicinal products that, if pharma companies can correctly harness, will turn the continent into a superpower for clinical trials. Therefore, they are open to clinical trials, because of the lack of costs that they have to put towards it.

article thumbnail

Clinical trials in Ukraine: Ensuring supply chain continuity during war

Pharmaceutical Technology

Alongside providing continuity of clinical trial services, Oximio has been involved in delivering life-saving humanitarian aid around the country. Olga has also recently been elected to provide logistics insight to the Clinical Trials Subcommittee (CTS) Executive Board at the European Business Association (EBA) due to the war.